Dr. Sean Nikravan, MD (he/him) is an Endocrinologist in Newport beach, CA with over 17 years of experience. What is your opinion of Dr. Sean Nikravan, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sean Nikravan, MD has received over $263,880 which includes payments from the following companies:
$143,510.03 from Janssen Pharmaceuticals, Inc
$42,300.43 from AbbVie, Inc.
$22,750.00 from Boehringer Ingelheim Pharmaceuticals, Inc.
$21,888.99 from AstraZeneca Pharmaceuticals LP
$9,392.94 from sanofi-aventis U.S. LLC
$5,908.03 from E.R. Squibb & Sons, L.L.C.
$5,840.04 from LILLY USA, LLC
$2,318.95 from Arbor Pharmaceuticals, Inc.
$2,211.53 from Takeda Pharmaceuticals America, Inc.
$1,643.48 from Animas Corporation
$1,011.22 from Amgen Inc.
$670.07 from Antares Pharma, Inc.
$550.14 from MannKind Corporation
$464.21 from Novo Nordisk Inc
$441.66 from Dexcom, Inc.
$346.35 from INSULET CORPORATION
$226.29 from Medtronic MiniMed, Inc.
$221.63 from Abbott Laboratories
$210.34 from Shire North American Group Inc
$203.86 from Corcept Therapeutics
Payments received by Dr. Sean Nikravan, MD were from the following categories:
$220,140.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!